Martin J. Gilligan
Corporate Officer/Principal at PHATHOM PHARMACEUTICALS, INC.
Profile
Martin J.
Gilligan is currently the Chief Commercial Officer at Phathom Pharmaceuticals, Inc. Previously, he worked as the VP-Inflammation & Immunology at Celgene Corp.
He holds an MBA from Rutgers State University of New Jersey and an undergraduate degree from Providence College.
Martin J. Gilligan active positions
| Companies | Position | Start |
|---|---|---|
| PHATHOM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2020-01-05 |
Former positions of Martin J. Gilligan
| Companies | Position | End |
|---|---|---|
| CELGENE | Corporate Officer/Principal | - |
Training of Martin J. Gilligan
| Providence College | Undergraduate Degree |
| Rutgers State University of New Jersey | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| PHATHOM PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
- Stock Market
- Insiders
- Martin J. Gilligan
